Pfizer (PFE) earnings

Earnings (net income) · fiscal 2025
$7.77B

Pfizer (PFE) reported net income of $7.77B in fiscal 2025 (the year ended December 31, 2025). That is 3.2% lower than the $8.03B of fiscal 2024. Figures as of 18 Nov 2026, 01:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$7.77B
Change on fiscal 2024
−3.2%
Growth, 5 years
−3.2% a year
Growth, 10 years
+1.1% a year
Highest on record
$31.37Bfiscal 2022
Lowest on record
$2.12Bfiscal 2023
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pfizer earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 3.2% a year; over ten years the rate was 1.1% a year. Across the 19 fiscal years on record (2007–2025), the highest was $31.37B in fiscal 2022 and the lowest $2.12B in fiscal 2023.

History · 19 fiscal years

Earnings (net income) by fiscal year

Pfizer earnings, year by year

Pfizer (PFE) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$7.77B 3.2% down
2024$8.03B 279.0% up
2023$2.12B 93.2% down
2022$31.37B 42.7% up
2021$21.98B 140.0% up
2020$9.16B 42.8% down
2019$16.03B 43.7% up
2018$11.15B 47.7% down
2017$21.31B 195.3% up
2016$7.22B 3.7% up
2015$6.96B 23.8% down
2014$9.14B 58.5% down
2013$22.00B 51.0% up
2012$14.57B 45.6% up
2011$10.01B 21.2% up
2010$8.26B 4.4% down
2009$8.64B 6.6% up
2008$8.10B 0.5% down
2007$8.14B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Pfizer and comparable companies
CompanyEarnings (net income)Fiscal year
Abbott Laboratories ABT$6.52B2025
Novo Nordisk NVODKK 102.43B2025
Pfizer PFE$7.77B2025
Danaher DHR$3.61B2025
Intuitive Surgical ISRG$2.86B2025
Vertex Pharmaceuticals VRTX$3.95B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PFE

Pfizer, figure by figure

Pfizer (PFE) overview: price, valuation and scorecardAll health care companies by market value

Pfizer earnings: questions and answers

What is Pfizer's net income?

Pfizer (PFE) reported net income of $7.77B in fiscal 2025 (the year ended December 31, 2025). That is 3.2% lower than the $8.03B of fiscal 2024.

What is the growth rate of Pfizer's net income?

Over the five fiscal years to 2025 net income shrank at a compound 3.2% a year; over ten years the rate was 1.1% a year.

What are the highest and lowest net income figures on record for Pfizer?

Across the 19 fiscal years on record (2007–2025), the highest was $31.37B in fiscal 2022 and the lowest $2.12B in fiscal 2023.

How is Pfizer's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pfizer (PFE) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/PFE/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.